Scribd Logo
Upload

Welcome to Scribd!

  • 21 views

    HFA Discoveries Programme

    Uploaded by

    Corina Diaconescu
    The document contains a schedule for sessions at a conference happening between June 5-19. It lists the days of the week and times for various late-breaking science sessions and talks on topics relating to valvular heart disease, acute heart failure, heart failure with preserved ejection fraction, inotropes and inodilators, COVID-19 and heart failure, cardiac remodelling, outcomes, registries, treating hyperkalaemia, SGLT-2 inhibitors in heart failure, and prevention. Many of the sessions are sponsored by pharmaceutical companies.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    HFA Discoveries Programme

    Uploaded by

    Corina Diaconescu
    21 views1 page
    The document contains a schedule for sessions at a conference happening between June 5-19. It lists the days of the week and times for various late-breaking science sessions and talks on topics relating to valvular heart disease, acute heart failure, heart failure with preserved ejection fraction, inotropes and inodilators, COVID-19 and heart failure, cardiac remodelling, outcomes, registries, treating hyperkalaemia, SGLT-2 inhibitors in heart failure, and prevention. Many of the sessions are sponsored by pharmaceutical companies.

    Original Description:

    Original Title

    HFA-Discoveries-Programme

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document contains a schedule for sessions at a conference happening between June 5-19. It lists the days of the week and times for various late-breaking science sessions and talks on topics relating to valvular heart disease, acute heart failure, heart failure with preserved ejection fraction, inotropes and inodilators, COVID-19 and heart failure, cardiac remodelling, outcomes, registries, treating hyperkalaemia, SGLT-2 inhibitors in heart failure, and prevention. Many of the sessions are sponsored by pharmaceutical companies.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    21 views1 page

    HFA Discoveries Programme

    Uploaded by

    Corina Diaconescu
    The document contains a schedule for sessions at a conference happening between June 5-19. It lists the days of the week and times for various late-breaking science sessions and talks on topics relating to valvular heart disease, acute heart failure, heart failure with preserved ejection fraction, inotropes and inodilators, COVID-19 and heart failure, cardiac remodelling, outcomes, registries, treating hyperkalaemia, SGLT-2 inhibitors in heart failure, and prevention. Many of the sessions are sponsored by pharmaceutical companies.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 1

    Programme

    Time Friday Wednesday Friday Monday Tuesday Friday


    (CEST) 5 June 10 June 12 June 15 June 16 June 19 June

    Late-Breaking Valvular heart SGLT-2 inhibitors Late-Breaking


    17:00 Science Session 1 – disease in setting in heart failure: Science Session 6 –
    17:45 Clinical trial update of acute heart failure beyond Pharmacotherapy
    Late-Breaking Late-Breaking glycaemic control
    Science Session 3 – Science Session 4 –
    17:50 Inotropes and HFpEF Acute heart failure
    Experts on the Spot:
    18:05 inodilators in
    Cardiac remodelling
    acute and advanced
    and outcomes
    heart failure
    18:10
    18:20 By Novartis Pharma AG
    By Orion Pharma

    Late-Breaking Universal definition COVID-19 and Late-Breaking Hot topics Late-Breaking


    of heart failure heart failure Science Session 5 – in heart failure Science Session 7 –
    18:25 Science Session 2 –
    19:10 Registries Monitoring Prevention

    Reversing cardiac SGLT2 inhibition:


    19:15 remodelling and Treating Making waves in the
    19:25 improving outcomes hyperkalaemia heart failure
    in heart failure: landscape
    19:25 what are our first- By CHANGE IME in
    choice treatments? partnership with By CHANGE IME in
    20:00
    Leicester Diabetes Centre partnership with
    By Novartis Pharma AG Leicester Diabetes Centre

    You might also like